Trade Mark Journal No.2026/003 16 January 2026
WO0000001879067 (1,5,9,10,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:20 June 2025
Date of designation in the UK:
20 June 2025
The mark contains the colour black
International priority date claimed: 23 December 2024
(France)
(5108212)
- Class 1
- Stem cells for research; stem cells for scientific purposes; nutrition agents for processing living cells other than for medical purposes; cell culture media other than for medical purposes; delivery media; micro-tissues obtained from stem cells for research purposes; cell aggregates for research; culture matrix for research purposes.
- Class 5
- Pharmaceutical products; pharmaceutical preparations; pharmaceutical preparations for tissue regeneration; stem cells for medical or veterinary use; pluripotent stem cells intended for cell and gene therapies; cell culture media for medical or veterinary use; surgical implants obtained from stem cells; cell growth media for growing cells for medical use; culture matrices for medical or veterinary use; micro-tissues.
- Class 9
- Scientific apparatus for cell culture systems; scientific apparatus for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus for cell culture; incubators for cell culture; cell culture apparatus for laboratory use; software; software used for the collection, analysis, sorting, communication of biological information relating to stem cells; measuring apparatus for controlling the quality of cell production by encapsulation; cell or molecule encapsulated lines; microscopes; microfluidic chip parallelizing systems; microfluidic chip connectors.
- Class 10
- Apparatus for stem cell regeneration for medical use; apparatus for cell culture systems for medical purposes; apparatus for cell culture systems by encapsulation for medical purposes; apparatus for analyzing and sorting cell culture for medical purposes.
- Class 42
- Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; scientific research on the differentiation of pluripotent stem cells into differentiated cells; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing informations with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology; software development; research on controlling the quality of the production of cells by encapsulation; research on controlling the quality of cell therapy production.
TREEFROG THERAPEUTICS
Representative: AQUINOV, 12 Cours Xavier Arnozan, F-33000 BORDEAUX, FRANCE